Skip to main content

Animations

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • Research Podcast Cover

    Episode 27: The Development and Application of the Alpha-Synuclein Seed Amplification Assay with Claudio Soto

    Dr. Claudio Soto discusses his work in this area and how it has opened the doors for a variety of potential uses of the alpha-synuclein seed amplification assay.
    Learn more

  • Neuroscientist Claudio Soto, PhD, Awarded the 2024 Robert A. Pritzker Prize

    MJFF awarded Claudio Soto, PhD, the 2024 Robert A. Pritzker Prize for Leadership in Parkinson’s Research 
    Learn more

  • Patient speaks with doctor in an office

    Common Questions about New Vyalev Treatment for Parkinson’s

    Vyalev is a recently approved, under-the-skin, continuous infusion of levodopa/carbidopa.
    Learn more

  • brain illustrated

    PPMI: Fall Parkinson’s Research Conference Highlights

    Conference highlights from the study changing everything.
    Learn more

  • MDS-PAS 2024

    MDS-PAS 9th Annual Movement Disorders School: Empowering Neurology Residents for Patient Care

    Highlights from MJFF’s sponsored event, MDS-PAS 9th Annual Movement Disorders School for Neurology Residents on October 19-20. Read More.
    Learn more

  • Research Podcast Cover

    Episode 26: An Inside Look at the Edmond J. Safra Fellowship in Movement Disorders with Marcelo Merello and Sergio Castillo-Torres

    Dr. Marcelo Merello and Dr. Sergio Castillo-Torres share their insights and perspectives as a Fellowship Director and a Fellow in the program, respectively.
    Learn more

Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.